VisionMed
VisionMed is a US-based AI healthcare company that develops EMMA™, an agentic procedural intelligence platform analyzing surgical video to produce structured clinical documentation. It serves hospital systems and surgical departments across multiple specialties via enterprise licensing, with initial commercial availability in April 2025.
- Company typePrivate
- Founded2025
- Headquarters—
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What VisionMed does
VisionMed is a US-based AI healthcare technology company founded in 2025 that develops EMMA™, a procedural intelligence platform designed to convert surgical and interventional procedure video into structured clinical documentation, event timelines, and analytics. The company targets hospital systems and surgical departments performing procedures across multiple specialties, including laparoscopic, endoscopic, arthroscopic/orthopedic, ophthalmologic, and robotic surgery. VisionMed explicitly positions EMMA™ as a clinician-in-the-loop documentation and post-procedure review layer, disavowing autonomous diagnostic, therapeutic, or intra-procedural guidance use cases.
EMMA™ is built on a proprietary agentic architecture that the company distinguishes from generic LLM wrappers. It performs multimodal perception across procedural video, optional audio, EHR data, and device/tool telemetry, and applies temporal analysis and context persistence to interpret video as a continuous process rather than isolated frames. Outputs include draft procedural documentation, timestamped event timelines, and quality/workflow analytics suitable for reporting, training, and review. The platform is device-agnostic and deployable via edge, cloud, or hybrid configurations without workflow disruption or vendor lock-in, and is complemented by an ancillary First Person Intelligence headset module that supplies clinician-eye perspective.
VisionMed operates a direct enterprise sales motion with a quote-based engagement model, generating revenue through subscription/enterprise licensing of the EMMA™ platform. Initial commercial availability was announced in April 2025 with early evaluations underway in select clinical environments. The company has no disclosed institutional funding, employs a small founding team of three co-founders plus a software engineer, robotics engineer, and a clinical orthopedic advisor, and has pursued strategic collaborations with a global robotic surgery society and an unnamed IRB-approved research institution to support training and research initiatives.
VisionMed firmographics
Firmographics- Name
- VisionMed
- Legal name
- VisionMed
- Website
- https://visionmed.us
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- VisionMed is a US-based AI healthcare company that develops EMMA™, an agentic procedural intelligence platform analyzing surgical video to produce structured clinical documentation. It serves hospital systems and surgical departments across multiple specialties via enterprise licensing, with initial commercial availability in April 2025.
- Ownership category
- akta.pro rank
VisionMed industry classification
Industry- Product category
- Clinical AI Video Analytics
- NAICS
- Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- AI/ML Engineering & Model Development Services (BPAEAHAF), Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem) (HDAEANAC)
Keywords
VisionMed business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- EMMA™ Platform Subscription: VisionMed generates revenue through enterprise licensing of its EMMA™ procedural intelligence platform. Early commercial availability was announced in April 2025 with early evaluations underway in select clinical environments. The platform is positioned for scalable enterprise integration across hospital systems and surgical departments.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
VisionMed product offering
Product offeringCore offering
VisionMed develops and sells EMMA™, an AI-driven procedural intelligence platform that analyzes live or recorded surgical and interventional video using multimodal perception and context persistence to generate clinician-reviewed structured documentation, event timelines, and quality/workflow analytics. The platform is device-agnostic, deployable across edge, cloud, or hybrid configurations, and integrates with existing clinical workflows and OEM ecosystems without disruption. It is supplemented by the First Person Intelligence ancillary headset providing clinician-eye perspective integration.
Product overview
VisionMed offers a single unified AI platform called EMMA™ as its core product, augmented by an ancillary First Person Intelligence headset module. EMMA™ is a procedural intelligence platform that transforms raw procedural video data into structured documentation, event timelines, and analytics. The First Person Intelligence headset provides clinician-eye perspective integration with the core platform. Together, these products form the documentation, analytics, education, and intelligence layer for procedural medicine.
Differentiator
Problem solved
Functional benefit
Brands
- EMMA™: AI-driven procedural intelligence platform that analyzes live or recorded procedural video to generate structured documentation, event timelines, and analytics.
Products and services
- EMMA™ Platform AI-driven procedural intelligence platform that analyzes live or recorded procedural video using multimodal perception and context persistence to generate accurate, clinician-reviewed outputs including draft procedural documentation, event timelines with timestamps, and quality/workflow analytics. Integrates into existing clinical workflows and OEM ecosystems without disrupting how procedures are performed, with device-agnostic edge, cloud, or hybrid deployment.
- First Person Intelligence Ancillary headset engineered by VisionMed that integrates with EMMA™ to provide clinician-eye perspective across surgical and interventional procedures, supporting procedural context and advanced analytics.
Quantifiable outcome
- Reduces documentation burden on clinicians, contributing to reduced physician burnout
Companies that use VisionMed
Customer profileSegments3 records
Ideal customer profiles2 records
VisionMed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature7 records
VisionMed partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor and core.
- Unnamed IRB-Approved Research InstitutionminorVisionMed partnered in an IRB-approved study evaluating AI applications in surgeon training for robotic surgery (January 2026). The study assesses AI applications in surgeon training workflows within robotic surgery environments.
- Global Robotic Surgery SocietycoreVisionMed initiated a collaboration with a global robotic surgery society in October 2025 to support training, education, and research initiatives using AI-enabled procedural video analysis. The partnership focuses on advancing surgical training and education through AI analysis of procedural video data.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
VisionMed competitors and assessment
Company assessmentBroad incumbents
- Arthrex: Orthopedic surgical device leader with the Synergy.net ecosystem for arthroscopy and orthopedic procedural data. Adjacent incumbent in EMMA's orthopedic/arthroscopy use case, with strong surgeon relationships that complicate VisionMed's GTM in those specialties.
- Stryker: Medtech incumbent with the Mako robotic-assisted surgery platform and growing surgical-data and analytics offerings. Competes for hospital budgets in surgical AI and has the installed base and capital to scale procedural intelligence rapidly.
- Intuitive Surgical: Da Vinci robotic surgery platform leader with a deep installed base of procedure-capture hardware and an emerging portfolio of AI-enabled surgical intelligence (e.g., Case Insights). Closest comparable in combining procedural video capture with AI-driven analytics at scale.
- Touch Surgery (Digital Surgery, now Medtronic): AI-driven surgical training and procedure-planning platform acquired by Medtronic. Comparable in the procedural-intelligence and surgical-training use cases VisionMed targets, now embedded inside a major medtech incumbent with substantially greater distribution.
- Medtronic: Global medtech incumbent with the Hugo robotic surgery platform and Touch Surgery AI assets. Represents both a likely competitor (native AI documentation in its robotic ecosystem) and a potential strategic acquirer of VisionMed-class technology.
Direct peers
- Theator: AI-powered surgical video analytics platform that ingests operative footage to deliver intraoperative decision support, postoperative review, and surgeon-performance analytics. Direct overlap with EMMA's procedural intelligence, computer-vision-based event detection, and quality/training use cases in the OR.
- Activ Surgical: AI and computer-vision company building real-time surgical guidance and visualization overlays for laparoscopic and endoscopic procedures. Directly competes in procedural video AI and shares VisionMed's hardware-plus-software model (hardware attach + software intelligence).
- Proximie: Telepresence and augmented-reality platform for the operating room that captures procedural video, enables remote collaboration, and increasingly layers in AI analytics. Comparable in targeting hospital systems and surgical departments with a device-agnostic OR video workflow play.
Emerging players
- Surgical Theater: VR/AR surgical visualization platform converting imaging and procedural data into immersive 360° reconstructions for planning, training, and patient engagement. Adjacent in using rich procedural imagery to generate clinical intelligence and in targeting training/research workflows.
Others
- Verily (Alphabet): Alphabet's health-tech arm with prior strategic interest in surgical AI (legacy Verb Surgical JV with J&J). Adjacent ecosystem player and potential strategic partner/investor given VisionMed's Google event visibility.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
VisionMed social profiles
Digital presenceVisionMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
VisionMed leadership team
Management profileNumber of profiles
Profiles6 records
VisionMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VisionMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VisionMed
What does VisionMed do?
VisionMed develops and sells EMMA™, an AI-driven procedural intelligence platform that analyzes live or recorded surgical and interventional video using multimodal perception and context persistence to generate clinician-reviewed structured documentation, event timelines, and quality/workflow analytics. The platform is device-agnostic, deployable across edge, cloud, or hybrid configurations, and integrates with existing clinical workflows and OEM ecosystems without disruption. It is supplemented by the First Person Intelligence ancillary headset providing clinician-eye perspective integration.
Is VisionMed a public or private company?
VisionMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was VisionMed founded?
VisionMed was founded in 2025. It employs 11 to 50 people.
How does VisionMed make money?
One revenue line is on record: EMMA™ Platform Subscription.
Who are VisionMed's main competitors?
Broad incumbents on record are Arthrex, Stryker, Intuitive Surgical, Touch Surgery (Digital Surgery, now Medtronic) and Medtronic. Direct peers are Theator, Activ Surgical and Proximie. Surgical Theater is listed as an emerging player. Verily (Alphabet) is listed as an others.
Does VisionMed have an API?
No public API is recorded for VisionMed.
What industry is VisionMed in?
VisionMed's product category is Clinical AI Video Analytics. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of BPAEAHAF, AI/ML Engineering & Model Development Services. Its NAICS code is 541511 and its SIC code is 7372.